The frequency of anti-β2-glycoprotein I antibodies is low and these antibodies are associated with pulmonary hypertension in mixed connective tissue disease

Lupus

Volumn 18, Issue 7, 2009, Pages 618-621

  Hasegawa, E M ^a   Caleiro, M T C ^a   Fuller, R ^a   Carvalho, J F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anti 2 glycoprotein I antibody; Anticardiolipin; Antiphospholipid antibody; Lupus anticoagulant; Mixed connective tissue disease

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; ANTIIDIOTYPIC ANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FETUS WASTAGE; HUMAN; MALE; MIXED CONNECTIVE TISSUE DISEASE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SECOND TRIMESTER PREGNANCY; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; MIDDLE AGED;

ADULT; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; BETA 2-GLYCOPROTEIN I; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERTENSION, PULMONARY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE;

EID: 65649128936     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203308101719     Document Type: Article

References (23)

1. Hughes GRV. Thrombosis. Abortion, cerebral disease, and lupus anticoagulant. Br Med J 1983; 287: 1088-1089.
2. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
3. Sharp GC, Irwin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease: An apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972; 52: 148-158.
4. Miyata M, Suzuki K, Sakuma F, et al. Anticardiolipin antibodies are associated with pulmonary hypertension in patients with mixed connective tissue disease or systemic lupus erythematosus. Int Arch Allergy Immunol 1993; 100: 351-354.
5. Doria A, Ruffatti A, Calligaro A, et al. Antiphospholipid antibody in mixed connective tissue disease. Clin Rheumatol 1992; 11: 48-50.
6. Mendonça LL, Amengual O, Atsumi T, Khamashta MA, Hugues GRV. Most anticardiolipin antibodis in mixed connective tissue disease are beta2-glycoprotein independent. J Rheumatol 1998; 25: 189-190.
7. Komatireddy GR, Wang GS, Sharp GC, Hoffman RW. Antiphospholipid antibodies among anti-U1-70kDa autoantibody positive patients with mixed connective tissue disease. J Rheumatol 1997; 24: 319-322.
8. Somers E, Magder LS, Petri M. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. J Rheumatol 2002; 29: 2531-2536.
9. Wahl DG, Guilhermin F, de Maistre E, Perret-Guillaume C, Lecompete T, Thibaut G. Risk of venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus - a metaanalysis. Lupus 1997; 6: 467-473.
10. Miyata M, Kida S, Kanno T, et al. Pulmonary hypertension in MCTD: Report of two cases with anticardiolipin antibody. Clin Rheumatol 1992; 11: 195-201.
11. Vegh J, Szodoray P, Kappelmayer J, et al. Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertension. Scand J Immunol 2006; 64: 69-76.
12. Kasukawa R, Tojo T, Miyawaki S. Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp GC, (eds), Mixed connective tissue disease and antinuclear antiodies. Amsterdam: Elsevier; 1987. pp. 41-47.
13. Harris EN, Pierangeli S. The Anticardiolipin ELISA test. Clin Immunol Newsl 1991; 11: 33-44.
14. Wisloff F, Jacobsen EM, Liestol S. Laboratory diagnosis of the antiphospholipid syndrome. Thromb Res 2002; 108: 263-271.
15. Hoffman RW, Rettenmaier LJ, Takeda Y, et al. Human autoantibodies against the 70kd polypeptide of U1 small nuclear RNP are associated with HLA-DR4 among connective tissue disease patients. Arthritis Rheum 1990; 35: 94-101.
16. Kurata N, Tan EM. Identification of antibody to nuclear acidic antigens by counterimmunoelectrophoresis. Arthritis Rheum 1976; 19: 574-580.
17. Elkon KB, Culhane L. Partial immunochemical characterization of the Ro and La proteins using antibodies from patients with the sicca syndrome and lupus erythematosus. J Immunol 1984; 132: 2350-2356.
18. Tan EM, Peebles C. Quantitation of antibodies to Sm antigen and nuclear ribonucleoprotein by hemagglutination. In: Rose NR, FriedmanH, (eds), Manual of clinical immunology. 2nd ed.Washington: American Society of Microbiology; 1980. pp. 866-870.
19. Wahl DG, Guilhermin F, de Maistre E, Perret-Guillaume C, Lecompete T, Thibaut G. Meta-analisis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis. Lupus 1998; 7: 15-22.
20. Amengual O, Atsumi T, Khamashta MA, Koike T, Hughes GRV. Specificity of ELISA for antibody beta-2glycoprotein I in patients with antiphospholipid syndrome. Br J Rheumatol 1996; 35: 1239-1243.
21. Asherson RA, Cervera R. Pulmonary hypertension, antiphospholipid antibodies, and syndromes. Clin Rev Allergy Immunol 2007; 32: 153-158.
22. Stojanovich L. Pulmonary manifestations in antiphospholipid syndrome. Autoimmun Rev 2006; 5: 344-348.
23. Espinosa G, Cervera R, Font J, Asherson RA. The lung in the antiphospholipid syndrome. Ann Rheum Dis 2002; 61: 195-198.